/term/other-operating-charges/XKRX:241820 PCL (XKRX:241820) Other Operating Expense
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PCL Inc (XKRX:241820) » Definitions » Other Operating Expense

PCL (XKRX:241820) Other Operating Expense : ₩6,386 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is PCL Other Operating Expense?

PCL's Other Operating Expense for the three months ended in Mar. 2024 was ₩2,107 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩6,386 Mil.

PCL's quarterly Other Operating Expense declined from Sep. 2023 (₩1,289 Mil) to Dec. 2023 (₩918 Mil) but then increased from Dec. 2023 (₩918 Mil) to Mar. 2024 (₩2,107 Mil).

PCL's annual Other Operating Expense declined from Dec. 2021 (₩3,768 Mil) to Dec. 2022 (₩2,838 Mil) but then increased from Dec. 2022 (₩2,838 Mil) to Dec. 2023 (₩6,891 Mil).


PCL Other Operating Expense Historical Data

The historical data trend for PCL's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PCL Other Operating Expense Chart

PCL Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,381.70 2,387.49 3,767.78 2,837.60 6,890.62

PCL Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,675.11 2,072.03 1,288.68 918.29 2,106.97

PCL Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩6,386 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PCL Other Operating Expense Related Terms

Thank you for viewing the detailed overview of PCL's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


PCL (XKRX:241820) Business Description

Traded in Other Exchanges
N/A
Address
Star Valley No. 701, 99, Digitalro, 9gi, Geumcheongu, Seoul, KOR, 08510
PCL Inc is engaged in the development of vitro diagnostics products by SG Cap technology used in immobilizing disease biomarkers. It offers blood testing kit, multiplex antigen detection kits, and ultra-low volume non-contact liquid handling.In addition, the company offers platform services, such as sol-gel spotting service that immobilizes the customer's requested material using the SolB reagent; and SG ID service, which provides customers with a molecule of interest immobilized in the SolB reagent and identified.

PCL (XKRX:241820) Headlines

No Headlines